vitamins to take on semaglutide – Levers.Health SymptoGuard®: Relief from GLP-1 Side
Description
Eli Lillys orforglipron is the first oral non-peptide GLP-1 receptor agonist advancing in obesity and diabetes research
Metabolic pathway studies
Weight loss with GLP-1 medications like semaglutide can transform your health, but rapid changes may affect skin appearance
Ongoing studies explore patch efficacy further, particularly for preventive health in non-obese individuals
No pills
Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA
